Impact BioMedical, Inc. Financial Overview
Impact BioMedical, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.159; its P/E ratio is -0.15; Impact BioMedical, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.